跳至主要内容
临床试验/NCT01499329
NCT01499329Unknown不适用

Endovascular Treatment of Iliac Artery Occlusions or Stenoses Using the Zeus CC Stent System

be Medical1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Binary (≥ 50%) restenosis rate

研究概览

简要总结

The purpose of this study is to evaluate safety and performance of the balloon-expandable Zeus CC (Rontis AG) stent for the treatment of Trans-Atlantic Inter-Society Consensus (TASC) A, B, C and D iliac lesions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is older than 18 years
  • Patient must sign a written informed consent form that is approved by the ethics committee prior to index-procedure
  • Patient must be compliant with all follow-up visits
  • Patient suffers from intermittent claudication (Rutherford 1-3) or critical limb ischemia (Rutherford 4 and 5)
  • Patient's life expectancy is more than 2 years
  • Patient has iliac atherosclerotic de novo lesion(s) type A, B, C & D according to TASC-II classification
  • Target vessel diameter is between 5 and 9 mm
  • Target lesion has a baseline diameter stenosis of more than 50%
  • Patient has sufficient infra-inguinal run-off with at least a patent common femoral artery and deep femoral artery (both <50% stenosis)

排除标准

  • Patient has a life expectancy of less than 2 years
  • Patient is refusing to be compliant with all follow-up visits
  • Patient suffers from acute limb ischemia, defined as any sudden decrease in limb perfusion causing a potential threat to limb viability.
  • Patient is intolerant to anticoagulant or antiplatelet therapy such as aspirin, heparin, clopidogrel or ticlopidine drug therapy
  • Patient has already been treated with a stent in the ipsilateral target vessel
  • Patient suffered tissue loss in the target extremities, defined as Rutherford 6
  • Patient is already enrolled in this or another investigational device study
  • Patient had a coronary intervention within the last 60 days before enrolment into this study or there is a planned coronary intervention within 60 days of enrolment into this study
  • Use of alternative therapy (e.g. atherectomy, cutting balloon, laser, radiation therapy) as part of the index-procedure
  • Any planned surgical intervention within 30 days of the index-procedure
  • Patient has an abdominal aortic aneurysm that is likely to require repair within the next 2 years.
  • Patient has no sufficient infra-inguinal run-off (>50% stenosis). Patient inclusion is only possible if revascularization (endovascular or surgical) is performed in the same procedure with a peroperative angiographic control yielding <30% stenosis.
  • Target lesion is a restenotic lesion.
  • Target lesion is adjacent an aneurysm.
  • Target vessel perforation with documented contrast extravasation during index-procedure prior to stent placement.

结局指标

主要结局

Binary (≥ 50%) restenosis rate

时间窗: 12, 24 months

assessed by duplex ultrasound at the target lesion without the need for repeat TLR after the index-procedure in surviving patients with preserved limbs

次要结局

未报告次要终点

研究者

发起方
be Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验